Ketamine Associated With Morphine PCA After Total Hip Arthroplasty

NCT ID: NCT00797264

Last Updated: 2013-04-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-11-30

Study Completion Date

2010-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ketamine (an analgesic drug often associated with morphine in the treatment of Opioid Induced Hyperalgesia) is often mixed in Morphine PCA syringe. We make the hypothesis that ketamine administrated separately via a continuous infusion, could induced a better analgesic effect.

We will perform a randomised double blind study to determine the best infusion mode of intravenous ketamine, associated with morphine in PCA syringe or alone in continuous infusion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Double blind study to determine the best infusion mode of intravenous ketamine, associated with morphine in PCA syringe or alone in continuous infusion

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arthroplasty, Replacement, Hip

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Ketamine pre and per operative, and morphine postoperative

Group Type EXPERIMENTAL

Ketamine-Morphine

Intervention Type DRUG

Ketamine bolus preoperative and syringe pump peroperative, and morphine postoperative (PCA)

B

NaCl pre and per operative, and morphine postoperative

Group Type ACTIVE_COMPARATOR

Morphine

Intervention Type DRUG

Bolus preoperative of NaCl and syringe pump peroperative of NaCl, and morphine postoperative (PCA)

C

Ketamine and morphine postoperative

Group Type EXPERIMENTAL

Postoperative PCA of Ketamine and morphine

Intervention Type DRUG

Bolus preoperative of NaCl and syringe pump peroperative of Ketamine, and morphine postoperative (PCA)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ketamine-Morphine

Ketamine bolus preoperative and syringe pump peroperative, and morphine postoperative (PCA)

Intervention Type DRUG

Morphine

Bolus preoperative of NaCl and syringe pump peroperative of NaCl, and morphine postoperative (PCA)

Intervention Type DRUG

Postoperative PCA of Ketamine and morphine

Bolus preoperative of NaCl and syringe pump peroperative of Ketamine, and morphine postoperative (PCA)

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Ketamine pre and per operative, and morphine postoperative Ketamine Morphine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* total hip arthroplasty

Exclusion Criteria

* pre operative opioid administration
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Philippe SITBON, MD

Role: PRINCIPAL_INVESTIGATOR

Assistance Publique - Hôpitaux de Paris Hôpital Bicêtre

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service d'anesthesie-reanimation - Hôpital Bicêtre

Le Kremlin-Bicêtre, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P060402

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Methadone in THA for Post-op Pain and Opioid Reduction
NCT07227064 NOT_YET_RECRUITING PHASE3